Gentian Diagnostics AS (OSTO:GENTOO) E10: kr-0.94 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:GENTOO Gentian Diagnostics AS OSTO:GENTOO
60 GF Score
Price kr40.00
GF Value kr53.59
Valuation Modestly Undervalued
View Full Analysis

What is Gentian Diagnostics AS E10?

Gentian Diagnostics AS OSTO:GENTOO 60 E10 is kr-0.94 as of Jun. 2026. GuruFocus rates OSTO:GENTOO with a GF Score™ of 60/100 and a GF Value™ of kr53.59 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Gentian Diagnostics AS's adjusted earnings per share data for the three months ended in Jun. 2026 was kr0.290. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-0.94 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-17), Gentian Diagnostics AS's current stock price is kr40.00. Gentian Diagnostics AS's E10 for the quarter that ended in Jun. 2026 was kr-0.94. Gentian Diagnostics AS's Shiller PE Ratio of today is .


Gentian Diagnostics AS  (OSTO:GENTOo) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Gentian Diagnostics AS E10 Related Terms


Gentian Diagnostics AS E10 Historical Data

* Premium members only.

The historical data trend for Gentian Diagnostics AS's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gentian Diagnostics AS E10 Chart

Gentian Diagnostics AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.91

Gentian Diagnostics AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.02 -0.96 -0.91 -1.10 -0.94

OSTO:GENTOO vs ABT, SYK, MDT: E10 Comparison

For the Medical Devices subindustry, Gentian Diagnostics AS's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gentian Diagnostics AS Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gentian Diagnostics AS's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Gentian Diagnostics AS's Shiller PE Ratio falls into.


OSTO:GENTOO
60GF Score
Gentian Diagnostics AS OSTO:GENTOO
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gentian Diagnostics AS E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Gentian Diagnostics AS's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.29/141.5800*141.5800
=0.290

Current CPI (Jun. 2026) = 141.5800.

Gentian Diagnostics AS Quarterly Data

per share eps CPI Adj_EPS
201609 -0.426 104.200 -0.579
201612 -0.246 104.400 -0.334
201703 -0.381 105.000 -0.514
201706 0.029 105.800 0.039
201709 -0.355 105.900 -0.475
201712 -0.377 106.100 -0.503
201803 -0.277 107.300 -0.365
201806 -0.149 108.500 -0.194
201809 -0.038 109.500 -0.049
201812 -0.846 109.800 -1.091
201903 -0.473 110.400 -0.607
201906 -1.321 110.600 -1.691
201909 -0.337 111.100 -0.429
201912 -0.458 111.300 -0.583
202003 -0.359 111.200 -0.457
202006 -0.092 112.100 -0.116
202009 -0.453 112.900 -0.568
202012 -0.229 112.900 -0.287
202103 -0.319 114.600 -0.394
202106 -0.230 115.300 -0.282
202109 -0.440 117.500 -0.530
202112 -0.621 118.900 -0.739
202203 -0.430 119.800 -0.508
202206 -0.194 122.600 -0.224
202209 -0.610 125.600 -0.688
202212 -0.300 125.900 -0.337
202303 -0.040 127.600 -0.044
202306 0.060 130.400 0.065
202309 -0.050 129.800 -0.055
202312 -0.650 131.900 -0.698
202403 0.270 132.600 0.288
202406 0.300 133.800 0.317
202409 0.210 133.700 0.222
202412 2.090 134.800 2.195
202503 0.490 136.100 0.510
202506 -0.130 137.800 -0.134
202509 0.260 138.500 0.266
202512 0.220 139.100 0.224
202603 -1.320 141.030 -1.325
202606 0.290 141.580 0.290

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-0.94 mean?
Gentian Diagnostics AS (OSTO:GENTOO) has a E10 of kr-0.94 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Gentian Diagnostics AS and its competitors.
Is Gentian Diagnostics AS's E10 too high?
Gentian Diagnostics AS's current E10 is kr-0.94. Overall, Gentian Diagnostics AS has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gentian Diagnostics AS's E10 compare to ABT and SYK?
Gentian Diagnostics AS's E10 of kr-0.94 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Gentian Diagnostics AS and its competitors. Gentian Diagnostics AS's current E10 is kr-0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gentian Diagnostics AS stock overvalued right now?
Based on GuruFocus' analysis, Gentian Diagnostics AS (OSTO:GENTOO) is currently considered Modestly Undervalued. The stock's GF Value™ is kr53.59, compared to a current price of kr40.00 — trading 25.4% below its estimated fair value. The current E10 is kr-0.94. Gentian Diagnostics AS's overall GF Score™ is 60/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Gentian Diagnostics AS (OSTO:GENTOO), the current E10 is kr-0.94 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gentian Diagnostics AS (OSTO:GENTOO) Overvalued in 2026?

Based on GuruFocus' analysis, Gentian Diagnostics AS stock appears to be undervalued. The current stock price of kr40.00 is trading 25.4% below its estimated GF Value™ of kr53.59. GuruFocus considers Gentian Diagnostics AS to be Modestly Undervalued.

Key valuation signals for OSTO:GENTOO:

  • E10: kr-0.94
  • GF Value™: kr53.59 vs. price of kr40.00 (25.4% below fair value)
  • GF Score™: 60/100

No single metric tells the full story. See the OSTO:GENTOO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gentian Diagnostics AS Business Description

Other Exchanges GENT:Norway6FK:Germany
Address Bjornasveien 5, Moss, NOR, 1596
Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in vitro diagnostic reagents (IVD) for medical diagnostics and research. Its portfolio and pipeline of reagents span areas such as inflammation, severe infections, kidney diseases, heart failure, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP, among others. Geographically, it generates a majority of its revenue from Europe, followed by Asia and the United States of America.
60GF Score

Get the complete analysis for OSTO:GENTOO

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr40.00
Price
kr53.59
GF Value